Inflammatory Myofibroblastic Tumor Refractory to Three Lines of ALK Inhibitors and Combination Immunotherapy

Research Progress of Spironolactone as an Antagonist of NRG1-ERBB4 Pathway in the Treatment of Cognitive Impairment in Schizophrenia

Advances in Research on the Relationship Between Vitamin D and Coronary Artery Disease in Kawasaki Disease

Decision-Making under Uncertain Conditions: The Internist, as a Director of the Diagnostic/Therapeutic Pathway in Grey Zones